These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14559949)

  • 1. Prescription drug benefits and health status among Medicare patients.
    Moldawsky R
    JAMA; 2003 Oct; 290(15):1994; author reply 1994-5. PubMed ID: 14559949
    [No Abstract]   [Full Text] [Related]  

  • 2. The prescription-drug problem.
    Steinbrook R
    N Engl J Med; 2002 Mar; 346(11):790. PubMed ID: 11893789
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saving money on your prescription drugs.
    Johns Hopkins Med Lett Health After 50; 2010 Jan; 21(11):4-5. PubMed ID: 20336846
    [No Abstract]   [Full Text] [Related]  

  • 5. To cut costs, risky drug use.
    Consum Rep; 2011 Nov; 76(11):9. PubMed ID: 22022754
    [No Abstract]   [Full Text] [Related]  

  • 6. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing generic drug use in Medicare Part D: the role of government.
    Kohl H; Shrank WH
    J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887
    [No Abstract]   [Full Text] [Related]  

  • 8. The rising utilization and costs of prescription drugs.
    PHC4 FYI; 2004; (26):1-2. PubMed ID: 15344277
    [No Abstract]   [Full Text] [Related]  

  • 9. Favorable Formulary Placement of Branded Drugs in Medicare Prescription Drug Plans When Generics Are Available.
    Socal MP; Bai G; Anderson GF
    JAMA Intern Med; 2019 Jun; 179(6):832-833. PubMed ID: 30882842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription drug benefits: cost management issues for Medicare.
    Fox PD
    Health Care Financ Rev; 2003; 25(2):7-21. PubMed ID: 15124374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 76 things you should know about the new Medicare drug discount cards.
    Medicare Rights Center
    Care Manag J; 2004; 5(1):47-51. PubMed ID: 15793924
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacy compliance with a prescription-drug discount program.
    Knapp KK; Law AV; Hitchman C
    N Engl J Med; 2002 Jul; 347(2):146-7; author reply 146-7. PubMed ID: 12110750
    [No Abstract]   [Full Text] [Related]  

  • 14. The Medicare prescription drug plan: assisting our older patients.
    Klein MN
    ORL Head Neck Nurs; 2004; 22(4):34-5. PubMed ID: 15617318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy benefits for Medicare: a "triple-edged" sword.
    Penna P
    Manag Care Interface; 2001 Oct; 14(10):57-8. PubMed ID: 11688094
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlling spending for prescription drugs.
    Altman SH; Parks-Thomas C
    N Engl J Med; 2002 Mar; 346(11):855-6. PubMed ID: 11893800
    [No Abstract]   [Full Text] [Related]  

  • 17. Financial consequences of drug benefit plans.
    Motheral B; Sheth J
    JAMA; 2003 Jan 22-29; 289(4):423-4; author reply 424. PubMed ID: 12533119
    [No Abstract]   [Full Text] [Related]  

  • 18. Financial consequences of drug benefit plans.
    Hsu J; Reed M
    JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533118
    [No Abstract]   [Full Text] [Related]  

  • 19. Financial consequences of drug benefit plans.
    Clark BE; Garis RI
    JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533117
    [No Abstract]   [Full Text] [Related]  

  • 20. Access to Medicare Part D gap coverage more scarce in 2007.
    Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.